Showing results (281-290 of 432) with videos related to

Sort By:
Pageof 44
Computer Methods and Programs in Biomedicine|January 28, 2025
VAE-Surv: A novel approach for genetic-based clustering and prognosis prediction in myelodysplastic syndromesCesare Rollo, Corrado Pancotti, Flavio Sartori, et al.
The New England Journal of Medicine|April 15, 2005
DNA topoisomerase II in therapy-related acute promyelocytic leukemiaAnita R Mistry, Carolyn A Felix, Ryan J Whitmarsh, et al.
Haematologica|February 9, 2019
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failureMarie Sébert, Aline Renneville, Cécile Bally, et al.
Leukemia|January 12, 2026
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstatValeria Santini, Amer M Zeidan, Koen Van Eygen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Blood|February 6, 2008
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 casesJean-Jacques Kiladjian, Francisco Cervantes, Franck W G Leebeek, et al.
European Journal of Haematology|May 13, 2014
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 studyAristoteles Giagounidis, Ghulam J Mufti, Moshe Mittelman, et al.
Leukemia|October 7, 2021
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AMLMatthieu Duchmann, Orianne Wagner-Ballon, Thomas Boyer, et al.
Blood Advances|April 23, 2021
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromesGrace A Ward, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, et al.
Blood|December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Pageof 44